Telehealth System to Improve Quality of Life in Breast Cancer Survivors
E-Cuidate: Effectiveness of a Telerehabilitation System in Women Breast Cancer Survivors
1 other identifier
interventional
72
1 country
1
Brief Summary
Background: Cancer is increasingly viewed as a chronic disease and therefore there is a growing need for long-term treatments. Breast cancer survivors suffer physical impairment after oncology treatment. This impairment reduces quality of life (QoL) and increases the prevalence of conditions associated to unhealthy life-style. Objective: The overall objective of e-Cuidate telerehabilitation will be to evaluate short and long-term effects telehealth program. Methods: Seventy-two breast cancer survivors (age range: 18-65 years) will be recruited through oncology and breast units at the Virgen de las Nieves Hospital and San Cecilio Hospital and associations of breast cancer patients in Granada. Patients will be randomized to receive the online rehabilitation group (n=36) or usual care (control) group (n=36). Telerehabilitation group will receive an eight-week online intervention and control group receive recommendations about usual care. Discussion: The investigators study attempts to increase the level of fitness and reduce musculoskeletal disorders in breast cancer patients through a strategy for care based on telerehabilitation to promote therapeutic exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started Mar 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 27, 2013
CompletedFirst Posted
Study publicly available on registry
February 28, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedOctober 27, 2017
October 1, 2017
1.9 years
February 27, 2013
October 25, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality of life
The primary outcome will be assessed with The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) version 3.0. This questionnaire includes both multi-item scales and single-item measures. These are composed by five functional scales, three symptom scales, a global health status/QoL scale, and six single items. The scores have to be averaged and transformed linearly to obtain a range of score from 0 to 100 where high score meaning a great response level. The European Organization for Research and Treatment of Cancer Breast Cancer-Specific Quality of Life Questionnaire (EORTC QLQ-BR23) which is a breast cancer module of EORTC QLQ-C30 will also be assessed
Participants will be followed over 8 weeks
Secondary Outcomes (10)
Algometry
Participants will be followed over 8 weeks
The Visual Analogue Scale (VAS) for pain
Participants will be followed over 8 weeks
Pain
Participants will be followed over 8 weeks
Body composition
Participants will be followed over 8 weeks
Physical measurement
Participants will be followed over 8 weeks
- +5 more secondary outcomes
Study Arms (2)
Telerehabilitation group
EXPERIMENTALControl group
NO INTERVENTIONInformation about usual care
Interventions
Interventions will be based on to provide cardiovascular, mobility, strength and stretching exercises through telerehabilitation system
Eligibility Criteria
You may qualify if:
- Diagnosis of stage I, II, or IIIA breast cancer
- Medical clearance of participation
- Without chronic disease or orthopaedic that would interfere with ability to participate in a physical activity program
- Access to Internet
- Basic ability to use the computer or living with a relative who has this ability
- Completion of adjuvant therapy except for hormone therapy
- No history of cancer recurrence
- Have interest in improving lifestyle: fitness/stress level
- Have signed informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidad de Granadalead
- Carlos III Health Institutecollaborator
Study Sites (1)
Faculty of Health Sciences. University of Granada
Granada, 18071, Spain
Related Publications (2)
Galiano-Castillo N, Arroyo-Morales M, Ariza-Garcia A, Fernandez-Lao C, Fernandez-Fernandez AJ, Cantarero-Villanueva I. Factors that Explain the Cancer-Related Insomnia. Breast J. 2017 Jul;23(4):387-394. doi: 10.1111/tbj.12759. Epub 2017 Jan 24.
PMID: 28117498DERIVEDGaliano-Castillo N, Ariza-Garcia A, Cantarero-Villanueva I, Fernandez-Lao C, Diaz-Rodriguez L, Legeren-Alvarez M, Sanchez-Salado C, Del-Moral-Avila R, Arroyo-Morales M. Telehealth system (e-CUIDATE) to improve quality of life in breast cancer survivors: rationale and study protocol for a randomized clinical trial. Trials. 2013 Jun 22;14:187. doi: 10.1186/1745-6215-14-187.
PMID: 23799886DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Manuel Arroyo-Morales, PhD
Faculty of Health Sciences. University of Granada
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
February 27, 2013
First Posted
February 28, 2013
Study Start
March 1, 2012
Primary Completion
February 1, 2014
Study Completion
July 1, 2014
Last Updated
October 27, 2017
Record last verified: 2017-10